Antimicrobial proteins and peptides of blood: Templates for novel antimicrobial agents

Blood

Volumn 96, Issue 8, 2000, Pages 2664-2672

  Levy, Ofer ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL PROTEIN; ATTACIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CATHELICIDIN DERIVATIVE; CECROPIN; CELL PROTEIN; DEFENSIN; DERMASEPTIN; DIPTERICIN; DROSOMYCIN; LACTOFERRIN; LIPID TRANSFER PROTEIN; LYSOZYME; MAGAININ DERIVATIVE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; PHOSPHOLIPASE; SERPROCIDIN DERIVATIVE; THIONINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; GENETIC SUSCEPTIBILITY; NONHUMAN; PATHOPHYSIOLOGY; PHYLOGENY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY BURST; REVIEW; TISSUE PERFUSION;

EID: 0034667551     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2664     Document Type: Review

References (146)

1. Phylogenetic perspectives in innate immunity
2. NADPH oxidase: An update
3. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing
4. The molecular basis of chronic granulomatous disease
5. Nitric oxide and macrophage function
6. Bacterial infection induces nitric oxide synthase in human neutrophils
7. Macrophage NRAMP1 and its role in resistance to microbial infections
8. Host resistance to intracellular infection: Mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification
9. Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections
10. Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes
11. Phagocytin: A bactericidal substance from polymorphonuclear leukocytes
12. Antibiotic proteins of polymorphonuclear leukocytes
13. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity
14. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria
15. Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein
16. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2
17. Structure, function, and membrane integration of defensins
18. Antimicrobial peptides of phagocytes and epithelia
19. Innate immunity of insects
20. Innate immunity in higher insects
21. Antimicrobial peptides in insects; structure and function
22. The toll of innate immunity on microbial pathogens
23. Peptide antibiotics and their role in innate immunity
24. Plant defense peptides
25. Antimicrobial peptides: Complementing classical inflammatory mechanisms of defense
26. Epithelial antibiotics induced at sites of inflammation
27. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2
28. The phagocyte system and disorders of granulopoiesis and granulocyte function
29. Granules of the human neutrophilic polymorphonuclear leukocyte
30. Holocrine secretion of calprotectin: A neutrophil-mediated defense against C. albicans?
31. Stucture of human lactoferrin at 3.2 angstrom resolution
32. Iron, infections, and anemia of inflammation
33. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111
34. Bactericidal domain of lactoferrin: Detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry
35. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalo-virus replication in vitro
36. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein
37. Endotoxin interactions with lipopolysaccharide-responsive cells
38. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets
39. Role of the bactericidal/permeability-increasing protein in host defence
40. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution
41. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains
42. 21) on growth and TN F-inducing activity of Gram-negative bacteria tested in neonatal cord blood ex vivo
43. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopoly-saccharide
44. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria
45. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates
46. 2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli
47. Bactericidal/permeability-increasing protein inhibits growth of a strain of Acholeplasma laidlawii and L forms of the gram-positive bacteria Staphyloccus aureus and Streptococcus pyogenes
48. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense
49. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate
50. 2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria
51. LPS-binding proteins and receptors
52. Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS
53. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins
54. Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: Defensins and azurocidin
55. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties
56. Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena
57. The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids
58. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis
59. Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation
60. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain
61. Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: Comparative mapping of the locus for the human peptide antibiotic FALL-39
62. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes
63. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders
64. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma
65. Protegrin-1: A broad-spectrum, rapidly microbicidal peptide with in vivo activity
66. Oligomerization of protegrin-1 in the presence of DPC micelles. A proton high-resolution NMR study
67. Structure and functions of endotoxin-binding peptides derived from CAP18
68. p15s (15-kD antimicrobial proteins) are stored in the secondary granules of rabbit granulocytes: Implications for antibacterial synergy with the bactericidal/permeability-increasing protein in inflammatory fluids
69. Improved activity of a synthetic indolicidin analog
70. Synergic antistaphylococcal properties of lactoferrin and lysozyme
71. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
72. Bactericidal action of lysozymes attached with various sizes of hydrophobic peptides to the C-terminal using genetic modification
73. Antimicrobial properties of human lysozyme transgenic mouse milk
74. Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli
75. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases
76. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears
77. Protection by group II phospholipase A2 against S. aureus
78. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes
79. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin
80. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants
81. Defensins and other endogenous peptide antibiotics of vertebrates
82. Crystal structure of defensin HNP-3, an amphiphilic dimer: Mechanisms of membrane permeabilization
83. Human beta-defensin-1: An antimicrobial peptide of urogenital tissues
84. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
85. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects
86. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins
87. Eosinophils
88. Comparison of intracellular bactericidal activities of human neutrophils and eosinophils
89. Bactericidal action of eosinophils from normal human blood
90. Developmental biology of neutrophils and eosinophils
91. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins
92. Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence
93. Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi
94. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein
95. Localization of eosinophil granule major basic protein in paracoccidioidomycosis lesions
96. A novel and highly divergent homolog of human eosinophil granule major basic protein
97. Recombinant human eosinophil cationic protein: Ribonuclease activity is not essential for cytotoxicity
98. Mechanism of membrane damage mediated by human eosinophil cationic protein
99. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes
100. Ultrastructural localization of lysozyme in human colon eosinophils using the protein A-gold technique: Effects of processing on probe distribution
101. The bactericidal/permeability-increasing protein (BPI) is present in specific granules of human eosinophils
102. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity
103. Development and distribution of mononuclear phagocytes
104. The structure of the rabbit macrophage defensin genes and their organ-specific expression
105. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes
106. Antimicrobial proteins of murine macrophages
107. Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages
108. Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin
109. Macrophages expressing a fusion protein derived from bactericidal/permeability-increasing protein and IgG are resistant to endotoxin
110. Perforin: Structure and function
111. The role of granzyme B cluster proteases in cell-mediated cytotoxicity
112. Granzymes: A variety of serine protease specificities encoded by genetically distinct subfamilies
113. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense
114. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity
115. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity
116. Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin
117. An antimicrobial activity of cytolytic T cells mediated by granulysin
118. The role of platelets in antimicrobial host defense
119. The role of hemolymph coagulation in innate immunity
120. Effect of thrombocytopenia on the early course of streptococcal endocarditis
121. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein
122. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro
123. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action
124. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates
125. The effect of chloride concentration on human neutrophil functions: Potential relevance to cystic fibrosis
126. Neutrophil antibodies
127. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia
128. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin
129. Biodiversity of apidaecin-type peptide antibiotics. Prospects of manipulating the antibacterial spectrum and combating acquired resistance
130. Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters
131. IB-367 reduces the number of days of severe oral mucositis complicating myeloabiative chemotherapy
132. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein
133. Recombinant endotoxin binding protein (rBPI23) attentuates endotoxin-induced circulatory changes in humans
134. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis
135. Impaired innate immunity in the newborn: Newborn neutrophils are deficient in bactericidal/permeability-increasing protein (BPI)
136. Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease
137. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model
138. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model
139. Penetration of the insect defensin A into phospholipid monolayers and formation of defensin A-lipid complexes
140. Insect immunity. The inducible antibacterial peptide diptericin carries two O-glycans necessary for biological activity
141. Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides
142. Attacin-an insect immune protein-binds LPS and triggers the specific inhibition of bacterial outer-membrane protein synthesis
143. Insect lysozymes
144. Lethal effect apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets
145. The dermaseptin precursors: A protein family with a common preproregion and a variable C-terminal antimicrobial domain